| Primary |
| Benign Prostatic Hyperplasia |
32.9% |
| Drug Use For Unknown Indication |
12.9% |
| Pain |
11.4% |
| Hypertension |
10.0% |
| Product Used For Unknown Indication |
4.3% |
| Prophylaxis Urinary Tract Infection |
4.3% |
| Asthma |
2.9% |
| Nocturia |
2.9% |
| Urinary Retention |
2.9% |
| Antibiotic Therapy |
1.4% |
| Antiplatelet Therapy |
1.4% |
| Arthritis |
1.4% |
| Blood Pressure |
1.4% |
| Blood Pressure Abnormal |
1.4% |
| Blood Pressure Increased |
1.4% |
| Cardiospasm |
1.4% |
| Cellulitis |
1.4% |
| Constipation |
1.4% |
| Deep Vein Thrombosis |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Drug Ineffective |
13.8% |
| Urinary Retention |
13.8% |
| Whiplash Injury |
10.3% |
| Orthostatic Hypotension |
6.9% |
| Abdominal Pain |
3.4% |
| Abdominal Pain Upper |
3.4% |
| Asphyxia |
3.4% |
| Atrioventricular Block First Degree |
3.4% |
| Cholelithiasis Obstructive |
3.4% |
| Circulatory Collapse |
3.4% |
| Diabetic Coma |
3.4% |
| Diplopia |
3.4% |
| Drug Effect Decreased |
3.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.4% |
| Dysarthria |
3.4% |
| Dysuria |
3.4% |
| Erectile Dysfunction |
3.4% |
| Fall |
3.4% |
| Gastric Cancer |
3.4% |
| Hepatic Function Abnormal |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
39.8% |
| Benign Prostatic Hyperplasia |
9.5% |
| Hypertension |
7.1% |
| Atrial Fibrillation |
6.2% |
| Pain |
5.2% |
| Type 2 Diabetes Mellitus |
3.3% |
| Hiv Test Positive |
2.8% |
| Infection |
2.8% |
| Septic Shock |
2.8% |
| Allergic Granulomatous Angiitis |
2.4% |
| Arrhythmia |
1.9% |
| Cardiac Failure Congestive |
1.9% |
| Folate Deficiency |
1.9% |
| Hypertensive Heart Disease |
1.9% |
| Hypothyroidism |
1.9% |
| Insomnia |
1.9% |
| Platelet Aggregation Inhibition |
1.9% |
| Prophylaxis |
1.9% |
| Antibiotic Therapy |
1.4% |
| Blood Pressure |
1.4% |
|
| Urinary Retention |
11.6% |
| Stevens-johnson Syndrome |
9.3% |
| Cholestasis |
7.0% |
| Cytolytic Hepatitis |
7.0% |
| Renal Failure Acute |
7.0% |
| Thrombocytopenia |
7.0% |
| Whiplash Injury |
7.0% |
| Acute Myocardial Infarction |
4.7% |
| Hepatocellular Injury |
4.7% |
| Hyperthermia |
4.7% |
| Pulmonary Alveolar Haemorrhage |
4.7% |
| Renal Failure Chronic |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Abdominal Discomfort |
2.3% |
| Abdominal Wall Haematoma |
2.3% |
| Allergic Granulomatous Angiitis |
2.3% |
| Atrial Fibrillation |
2.3% |
| Cardiac Failure |
2.3% |
| Diplopia |
2.3% |
| Drug Interaction |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Drug Use For Unknown Indication |
23.8% |
| Hypertension |
7.8% |
| Benign Prostatic Hyperplasia |
5.2% |
| Pneumonia |
3.7% |
| Rheumatoid Arthritis |
3.2% |
| Hypercholesterolaemia |
3.1% |
| Atrial Fibrillation |
2.8% |
| Essential Hypertension |
2.6% |
| Prostate Cancer |
2.6% |
| Pain |
2.4% |
| Prophylaxis |
2.4% |
| Tuberous Sclerosis |
2.4% |
| Anaemia |
2.3% |
| Colorectal Cancer Metastatic |
2.1% |
| Depression |
2.1% |
| B-cell Lymphoma |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Prostatic Disorder |
1.9% |
| Acute Coronary Syndrome |
1.6% |
|
| Urinary Retention |
11.4% |
| Urinary Tract Infection |
11.4% |
| Renal Failure Acute |
6.3% |
| Rheumatoid Arthritis |
6.3% |
| Tendon Rupture |
6.3% |
| Upper Gastrointestinal Haemorrhage |
5.1% |
| Visual Impairment |
5.1% |
| Cardiogenic Shock |
3.8% |
| Drug Ineffective |
3.8% |
| Flushing |
3.8% |
| Pain In Extremity |
3.8% |
| Pneumonia |
3.8% |
| Rash |
3.8% |
| Rash Maculo-papular |
3.8% |
| Respiratory Failure |
3.8% |
| Sensory Disturbance |
3.8% |
| Septic Shock |
3.8% |
| Therapeutic Product Ineffective |
3.8% |
| Thrombocytopenia |
3.8% |
| Anaemia |
2.5% |
|
